Shimabukuro M - Search Results

1

[Obesity syndrome as a critical risk for the onset of type 2 diabetes].

Masuzaki H, Yabiku K, Ueda R, Kozuka C, Taira S, Shimabukuro M. Masuzaki H, et al. Among authors: shimabukuro m. Nihon Rinsho. 2012 May;70 Suppl 3:39-46. Nihon Rinsho. 2012. PMID: 22768493 Japanese. No abstract available.

2

[Appetite and feeding regulation by free fatty acid].

Shimabukuro M. Shimabukuro M. Nihon Rinsho. 2006 Dec 28;64 Suppl 9:116-20. Nihon Rinsho. 2006. PMID: 17458204 Review. Japanese. No abstract available.

3

Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitus.

Shimabukuro M, Higa M, Tanaka H, Shimabukuro T, Yamakawa K, Masuzaki H. Shimabukuro M, et al. Among authors: shimabukuro t. Diabet Med. 2011 Jul;28(7):856-64. doi: 10.1111/j.1464-5491.2011.03240.x. Diabet Med. 2011. PMID: 21244474 Clinical Trial.

4

Impaired glucose tolerance, but not impaired fasting glucose, underlies left ventricular diastolic dysfunction.

Shimabukuro M, Higa N, Asahi T, Yamakawa K, Oshiro Y, Higa M, Masuzaki H. Shimabukuro M, et al. Diabetes Care. 2011 Mar;34(3):686-90. doi: 10.2337/dc10-1141. Epub 2011 Feb 7. Diabetes Care. 2011. PMID: 21300789 Free PMC article.

5

[Obesity: Progress in diagnosis and treatment topics, IV. Recent topics; 1. Ectopic fat disposition and lipotoxicity].

Shimabukuro M, Yamakawa K, Masuzaki H, Sata M. Shimabukuro M, et al. Nihon Naika Gakkai Zasshi. 2011 Apr 10;100(4):983-8. doi: 10.2169/naika.100.983. Nihon Naika Gakkai Zasshi. 2011. PMID: 21626835 Japanese. No abstract available.

6

Effective prediction of response to cardiac resynchronization therapy using a novel program of gated myocardial perfusion single photon emission computed tomography.

Nakamura K, Takami M, Shimabukuro M, Maesato A, Chinen I, Ishigaki S, Higa S, Keida T, Masuzaki H. Nakamura K, et al. Among authors: shimabukuro m. Europace. 2011 Dec;13(12):1731-7. doi: 10.1093/europace/eur143. Epub 2011 Aug 25. Europace. 2011. PMID: 21873328

7

Intensive glucose lowering in cardiovascular risk management - unsolved questions -.

Shimabukuro M, Masuzaki H, Sata M. Shimabukuro M, et al. Circ J. 2012;76(3):593-5. doi: 10.1253/circj.cj-12-0062. Epub 2012 Jan 28. Circ J. 2012. PMID: 22293455 Free article. No abstract available.

8

Miglitol, α-glycosidase inhibitor, reduces visceral fat accumulation and cardiovascular risk factors in subjects with the metabolic syndrome: a randomized comparable study.

Shimabukuro M, Higa M, Yamakawa K, Masuzaki H, Sata M. Shimabukuro M, et al. Int J Cardiol. 2013 Sep 1;167(5):2108-13. doi: 10.1016/j.ijcard.2012.05.109. Epub 2012 Jun 20. Int J Cardiol. 2013. PMID: 22721642 Clinical Trial.

9

Activation of AMPK-Sirt1 pathway by telmisartan in white adipose tissue: A possible link to anti-metabolic effects.

Shiota A, Shimabukuro M, Fukuda D, Soeki T, Sato H, Uematsu E, Hirata Y, Kurobe H, Sakaue H, Nakaya Y, Masuzaki H, Sata M. Shiota A, et al. Among authors: shimabukuro m. Eur J Pharmacol. 2012 Oct 5;692(1-3):84-90. doi: 10.1016/j.ejphar.2012.07.026. Epub 2012 Jul 20. Eur J Pharmacol. 2012. PMID: 22819702

10

Brown rice and its component, γ-oryzanol, attenuate the preference for high-fat diet by decreasing hypothalamic endoplasmic reticulum stress in mice.

Kozuka C, Yabiku K, Sunagawa S, Ueda R, Taira S, Ohshiro H, Ikema T, Yamakawa K, Higa M, Tanaka H, Takayama C, Matsushita M, Oyadomari S, Shimabukuro M, Masuzaki H. Kozuka C, et al. Among authors: shimabukuro m. Diabetes. 2012 Dec;61(12):3084-93. doi: 10.2337/db11-1767. Epub 2012 Jul 23. Diabetes. 2012. PMID: 22826028 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters